Enhancement of human osteoblast proliferation and phenotypic expression when cultured in human serum
Open Access
- 1 January 2001
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 72 (4) , 395-403
- https://doi.org/10.1080/000164701753542069
Abstract
Traditionally, culture medium is supplemented with foetal bovine serum (FBS). However, in cultures of osteoblasts intended for human re-implantation, such serum presents potential risks of foreign protein contamination and transmission of viral or prionrelated material, if used. We cultured human osteoblasts from 16 patients in 10% autologous human serum, 10% pooled human serum, 10% FBS or 2% Ultroser G. Non-synthetic sera were tested in both heat-treated and non-heat-treated forms. We determined cell growth and osteoblast phenotype. Cell proliferation in all types of human serum was significantly greater than in FBS. This was most marked in heat-treated autologous human serum. Cells cultured in Ultroser G had less proliferation than all other groups. The phenotypic tests showed that cells cultured in human and foetal bovine serum displayed an osteoblast phenotype, with greater protein expression in cells cultured in human serum. We conclude that culture of human osteoblasts in autologous human serum enhances cell proliferation, while maintaining an osteoblast phenotype. These findings have implications for the use of cultured osteoblasts in self-cell therapy. Human osteoblast growth is supported by autologous human serum, which allows re-implantation of cultured cells, while avoiding the risk of foreign protein carry-over with enhancement of cell proliferation.Keywords
This publication has 23 references indexed in Scilit:
- Biocompatibility of xenogeneic bone, commercially available coral, a bioceramic and tissue sealant for human osteoblastsBiomaterials, 1994
- Extracellular protein secretion of cultured normal and Pagetic osteoblastsElectrophoresis, 1993
- Mesenchymal stem cellsJournal of Orthopaedic Research, 1991
- Study of the growth factor requirements of human bone-derived cells: A comparison with human fibroblasts☆Bone, 1989
- Inhibition of hydroxyapatite-crystal growth by bone-specific and other calcium-binding proteinsBiochemistry, 1986
- The use of Ultroser G as a serum substitute in the culture of human skin fibroblastsBiology of the Cell, 1986
- Culture of chondrocytes in medium supplemented with fetal calf serum or a serum substitute: Ultroser GBiology of the Cell, 1984
- Production of osteocalcin by human bone cells in vitro. Effects of 1,25(OH)2D3, 24,25(OH)2D3, parathyroid hormone, and glucocorticoidsMetabolic Bone Disease and Related Research, 1984
- Isolation of bone cell clones with differences in growth, hormone responses, and extracellular matrix production.The Journal of cell biology, 1982
- 1,25-Dihydroxyvitamin D3 increases serum levels of the vitamin K-dependent bone proteinBiochemical and Biophysical Research Communications, 1981